No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency

International Journal of Immunogenetics

Volumn 34, Issue 3, 2007, Pages 213-217

  Govan, V A ^a,b   Loubser, S ^a   Saleh, D ^a   Hoffman, M ^b   Williamson, A L ^a,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; PROTEIN P53;

ARTICLE; CAUCASIAN; CODON; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INDIAN; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PORTUGAL; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTH AFRICA; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

ARGININE; CASE-CONTROL STUDIES; CODON; FEMALE; GENE FREQUENCY; GENES, P53; GENOTYPE; HUMANS; PAPILLOMAVIRUS INFECTIONS; SOUTH AFRICA; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 34248531305     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2007.00678.x     Document Type: Article

References (29)

1. Arbel-Alon, S., Menczer, J., Feldman, N., Glezerman, M., Yeremin, L. Friedman, E. (2002) Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women. International Journal of Gynecological Cancer, 12, 741.
2. Beckman, G., Birgander, R., Sjalander, A., Saha, N., Holmberg, P.A., Kivela, A. Beckman, L. (1994) Is p53 polymorphism maintained by natural selection? Human Heredity, 44, 266.
3. Bhattacharya, P., Duttagupta, C. Sengupta, S. (2002) Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women. Cancer Letters, 188, 207.
4. DiPaolo, J.A. Alvarez-Salas, L.M. (2004) Advances in the development of therapeutic nucleic acids against cervical cancer. Expert Opinions on Biological Therapy, 4, 1.
5. Dokianakis, D.N. Spandidos, D.A. (2000) P53 codon 72 polymorphism as a risk factor in the development of HPV- associated cervical cancer. Molecular Cell Biology Research Communications, 3, 111.
6. Govan, V.A., Carrara, H.R., Sachs, J.A., Hoffman, M., Stanczuk, G.A. Williamson, A.-L. (2003) Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. Journal of Carcinogenesis, 2 (1 3.
7. zur Hausen, H. (2000) Papillomaviruses causing cancer: evasion from host-cell host in early events in carcinogenesis. Journal of the National Cancer Institute, 92, 690.
8. Hawley-Nelson, P., Vousden, K.H., Hubbert, N.L., Lowy, D.R. Schiller, J.T. (1989) HPV 16, E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO Journal, 8, 3905.
9. Hiyama, T., Tanaka, S., Kitadai, Y., Ito, M., Sumii, M., Yoshihara, M., Shimamoto, F., Haruma, K. Chayama, K. (2002) p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. International Journal of Cancer, 100, 304.
10. Hoffman, M., Cooper, D., Carrara, H.R.O., Rosenberg, L., Kelly, J., Stander, I., Williamson, A.-L., De toit, G. Shapiro, S. (2003) Limited Pap screening associated with reduced risk of cervical cancer in South Africa. International Journal of Epidemiology, 32, 573.
11. Hu, Y., McDermott, M.P. Ahrendt, S.A. (2005) The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer. Clinical Cancer Research, 11, 2502.
12. Inserra, P., Abrahamsen, M., Papenfuss, M. Giuliano, A.R. (2003) Ethnic variation of the P53 codon 72 polymorphism, HPV persistence, and cervical cancer risk. International Journal of STD & AIDS, 14, 800.
13. Koushik, A., Ghosh, A., Duarte-Franco, E., Forest, P., Voyer, H., Matlashewski, G., Coutlee, F. Franco, E.L. (2005) Biomarkers of Cervical Cancer Risk (BCCR) Study Team. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer Detection and Prevention, 29, 307.
14. Lane, A.B., Soodyall, H., Arndt, S., Ratshikhopha, M.E., Jonker, E., Freeman, C., Young, L., Morar, B. Toffie, L. (2002) Genetic substructure in South African Bantu speakers: evidence from autosomal DNA and Y-chromosome studies. American Journal of Physical Anthropology, 119, 175.
15. Matlashewski, G.J., Tuck, S., Pim, D., Lamb, P., Schneider, J. Crawford, L.V. (1987) Primary structure polymorphism at amino acid residue 72 of human p53. Molecular and Cellular Biology, 7, 961.
16. Munger, K., Phelps, W.C., Bubb, V., Howley, P.M. Schlegel, R. (1989) The E6 and E7 gene of human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. Journal of Virology, 63, 4417.
17. Papadakis, E.N., Dokianakis, D.N. Spandidos, D.A. (2000) Codon 72 polymorphism as a risk factor in the development of breast cancer. Molecular Cell Biology Research Communications, 3, 389.
18. Pegoraro, R.J., Rom, L., Lanning, P.A., Moodley, M., Naiker, S. Moodley, J. (2002) P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women. International Journal of Gynecological Cancer, 12, 383.
19. Santos, A.M., Sousa, H., Catarino, R., Pinto, D., Pereira, D., Vasconcelos, A., Matos, A., Lopes, C. Medeiros, R. (2005) TP53 codon 72 polymorphism and risk for cervical cancer in Portugal. Cancer Genetics and Cytogenetics, 159, 143.
20. Saranath, D., Khan, Z., Tandle, A.T., Dedhia, P., Sharma, B., Contractor, R., Shrivastava, S. Dinshaw, K. (2002) HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India. Gynecological Oncology, 86, 157.
21. Schiffman, M. Kjaer, S.K. (2003) Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. Journal of the National Cancer Institute. Monographs, 31, 14.
22. Senderowicz, A.M. (2001) Cyclin-dependent kinase modulators: a novel class of cell cycle regulators for cancer therapy. Cancer Chemothery and Biological Response Modifiers, 19, 165.
23. Settheetham-Ishida, W., Kanjanavirojkul, N., Kularbkaew, C. Ishida, T. (2005) Human papillomavirus genotypes and the p53 codon 72 polymorphism in cervical cancer of Northeastern Thailand. Microbiological Immunology, 49, 417.
24. Smotkin, D. Wettstein, F.O. (1986) Transcription of HPV16 early genes in a cervical cancer and a cervical cancer derived cell line, and the identification of the E7 protein. Proceedings of the National Academy of Sciences, USA, 83, 4680.
25. Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I.M., Matlashewski, G. Banks, L. (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature, 393, 229.
26. Thomas, M., Kalita, A., Labrecque, S., Pim, D., Banks, L. Matlashewski, G. (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Molecular and Cellular Biology, 19, 1092.
27. Tommiska, J., Eerola, H., Heinonen, M., Salonen, L., Kaare, M., Tallila, J. et al. (2005) Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival. Clinical Cancer Research, 11, 5098.
28. Wang, Y.C., Lee, H.S., Chen, S.K., Chang, Y.Y. Chen, Y. (1999) Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. European Journal of Cancer, 35, 226.
29. Weinberg, R.A. (1991) Tumor suppressor genes. Science, 254, 1138.